This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
National Institutes of Health Consensus Development Conference on Neurofibromatosis Announced.—
Neurofibromatosis is the subject of an upcoming consensus development conference sponsored by the National Institutes of Health (NIH). The conference is scheduled for July 13 to 15, 1987, in Masur Auditorium of the NIH Clinical Center and is open to the public. The purpose of the conference is to reach agreement on clinical types of neurofibromatosis, medical care of patients and their families, and research needs. Key questions to be addressed are the following: What are the various clinical types of neurofibromatosis, and what are their frequencies and their diagnostic criteria? What are the recommendations for care of patients and their families at diagnosis and during routine follow-up? What are the management options for major manifestations of neurofibromatosis? What are the key research areas that will improve our knowledge about prevention, diagnosis, and treatment of neurofibromatosis? The National Institute of
News and Notes. Arch Dermatol. 1987;123(4):447. doi:10.1001/archderm.1987.01660280049020